| Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > 13 Comments on Bad Meetings |
|
Other Articles - 13 Comments on Bad Meetings
Bad meetings are a cultural malady that senior executives pass on to According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product new
employees. Long pointless meetings are useful in that they kee ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in incompetent people from
interfering with those who are working. A lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. employee who needs permission to buy a box of paperclips can spend t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ns of
thousands of dollars worth of employee time on bad meetings. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro Many people attempt to save time by Not planning. This false short cu ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc guarantees
that everyone will spend more time later. Unstructured easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi spontaneity leads to serendipity, which (in business) leads to
bank nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically uptcy. Meetings are a magnetic opiate that keep people from the task and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ they were hired to
perform. The main activity in many meetings co ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi sists of simple chit chat. If it's an important
meeting, then this ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a becomes sincere chit chat. A meeting without an agenda is like a jou dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ney without a map. A teleconference without an agenda is like a jour cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ey without a map, in the dark. Most meetings are social street lamps tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen attracting the unproductive moths in an
organization. People fail t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel o prepare an agenda for two reasons. They think they’re saving time a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust d
they don’t know what to put in it. Expecting a meeting to produc y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products results without an agenda is like expecting the
Easter bunny to le . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ve eggs on your doorstep. Bad meetings waste a fortune. My surveys s elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ow that companies waste almost 20% of
their payroll on bad meetings tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Customers - What They Really Want - 6 Secrets of Customer Service Organisational Building - A Challenge To Meet Business Goals
|